Raphael Pharmaceutical (RAPH) Operating Expenses (2020 - 2024)

Raphael Pharmaceutical (RAPH) has 5 years of Operating Expenses data on file, last reported at $394000.0 in Q4 2024.

• For the quarter ending Q4 2024, Operating Expenses rose 632.43% year-over-year to $394000.0; the trailing twelve-month figure through Sep 2025 stood at $394000.0 (down 62.15% YoY), and the FY2025 full-year result was $648000.0, down 12.79% from the prior year.
• Operating Expenses improved to $394000.0 in Q4 2024, from $319000.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.4 million in Q3 2022 to a low of -$74000.0 in Q4 2023.
• A 5-year average of $471411.8 and a median of $394000.0 in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses slumped 106.7% in 2023 and soared 632.43% in 2024, its largest moves.
• Tracing RAPH's Operating Expenses over 5 years: stood at $227000.0 in 2020, then jumped by 152.86% to $574000.0 in 2021, then jumped by 92.33% to $1.1 million in 2022, then plunged by 106.7% to -$74000.0 in 2023, then soared by 632.43% to $394000.0 in 2024.
• Business Quant data shows RAPH's Operating Expenses at $394000.0 in Q4 2024, $319000.0 in Q3 2024, and $249000.0 in Q2 2024.